BeStock  
股票 › ESG投资 › MRK

默克 MRK

美股市值排名 #36传染病ESG投资癌症研究
$146.73 −$0.21 (-0.14%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $146.73 0.00%
开盘$144.34
昨收$146.94
当日区间$142.80 – $147.48
成交量7.63M
市值$361.73B
市盈率(TTM)148.2
股息率2.32%

基本面

最新报告季度:Q3, ended Sep 2026

营收$18.09B+4.7% YoY
营业利润$5.77B-12.0% YoY
净利润$5.07B-12.4% YoY
摊薄每股收益$2.04-12.1% YoY
自由现金流$4.48B+77.0% YoY
经营现金流$5.37B

营收,近8个季度

$15.6BDec '24$15.5BMar '25$15.8BJun '25$17.3BSep '25$16.4BDec '25$16.3BMar '26$16.6BJun '26$18.1BSep '26

净利润,近8个季度

$3.7BDec '24$5.1BMar '25$4.4BJun '25$5.8BSep '25$3.0BDec '25$-4.2BMar '26$-1.3BJun '26$5.1BSep '26

各季度摊薄每股收益

1.48Dec '242.01Mar '251.76Jun '252.32Sep '251.19Dec '25-1.72Mar '26-0.54Jun '262.04Sep '26

各季度自由现金流

$8.5BSep '24$2.5BDec '24$1.2BMar '25$2.5BJun '25$6.8BSep '25$1.8BDec '25$2.9BMar '26$4.5BJun '26

年度营收

$41.5BFY20$48.7BFY21$59.3BFY22$60.1BFY23$64.2BFY24$65.0BFY25

盈利能力与资产负债表

毛利率71.8%
营业利润率9.2%
净利率3.6%
负债/资产比率67.7%
现金及投资$7.14B
总负债$53.91B
净现金(净负债)-$46.77B

营收构成

2026/Q2 季度

按业务线

  • Pharmaceutical$14.76B 88.9%
  • Animal health$1.78B 10.7%
  • Other$72.00M 0.4%

利润表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
报告营业总收入 $18.09B $16.61B $16.29B $65.01B $16.40B
营业总收入 $18.09B $16.61B $16.29B $65.01B $16.40B
营业成本 $4.89B $4.40B $4.20B $16.38B $5.55B
毛利润 $13.19B $12.21B $12.09B $48.63B $10.85B
营业费用 $7.42B $12.65B $15.29B $26.52B $6.78B
销售及管理费用 $2.89B $2.90B $2.70B $10.73B $2.90B
研发费用 $4.54B $9.74B $12.59B $15.79B $3.89B
营业利润 $5.77B -$433.00M -$3.20B $22.11B $4.07B
其他收入(支出) -$211.00M $240.00M $111.00M -$26.00M -$303.00M
特殊收益(费用) -$184.00M -$151.00M -$195.00M -$889.00M -$213.00M
-减:重组及并购费用 $184.00M $151.00M $195.00M $889.00M $213.00M
其他非经营性收入(支出) -$27.00M $186.00M $176.00M $818.00M $204.00M
税前利润 $5.56B -$683.00M -$3.53B $21.07B $3.42B
税费 $492.00M $654.00M $709.00M $2.80B $458.00M
净利润 $5.07B -$1.34B -$4.24B $18.26B $2.96B
持续经营利润 $5.07B -$1.34B -$4.24B $18.26B $2.96B
少数股东权益 $2.00M -$2.00M -$3.00M $9.00M -$1.00M
归属母公司净利润 $5.07B -$1.34B -$4.24B $18.25B $2.96B
归属普通股股东净利润 $5.07B -$1.34B -$4.24B $18.25B $2.96B
基本每股收益 $2.05 -$0.54 -$1.72 $7.30 $1.20
摊薄每股收益 $2.04 -$0.54 -$1.72 $7.28 $1.19
每股股息 $0.85 $0.85 $0.85 $3.28 $0.85
非经营性利息净收入(支出) – -$490.00M -$444.00M -$1.01B -$342.00M
非经营性利息收入 – $35.00M $35.00M $343.00M $69.00M
非经营性利息支出 – $525.00M $479.00M $1.36B $411.00M
证券出售收益 – $205.00M $130.00M $45.00M -$294.00M

资产负债表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
总资产 $129.80B $128.69B $136.87B $136.87B $129.55B
流动资产合计 $36.68B $35.02B $43.52B $43.52B $47.56B
现金及现金等价物与短期投资 $7.14B $5.70B $14.57B $14.57B $18.21B
-现金及现金等价物 $6.85B $5.33B $14.57B $14.57B $18.17B
-短期投资 $292.00M $375.00M $0.00 $0.00 $45.00M
应收款 $12.56B $12.21B $11.78B $11.78B $12.12B
-应收账款 $12.56B $12.21B $11.78B $11.78B $12.12B
存货 $6.21B $6.48B $6.66B $6.66B $6.44B
其他流动资产 $10.77B $10.62B $10.52B $10.52B $10.78B
非流动资产合计 $93.12B $93.67B $93.35B $93.35B $81.99B
固定资产净值 $25.74B $25.43B $25.32B $25.32B $25.64B
-固定资产原值 $48.47B $47.72B $47.23B $47.23B $46.24B
-累计折旧 -$22.73B -$22.29B -$21.91B -$21.91B -$20.61B
投资及预付款 $1.22B $1.11B $956.00M $956.00M $1.12B
-交易性证券 $1.22B – $956.00M $956.00M $1.12B
商誉及其他无形资产 $46.56B $47.33B $48.26B $48.26B $36.90B
-商誉 $21.58B $21.58B $21.58B $21.58B $21.59B
-其他无形资产 $24.98B $25.75B $26.68B $26.68B $15.31B
其他非流动资产 $19.60B $19.81B $18.82B $18.82B $18.33B
负债合计 $87.82B $82.75B $84.20B $84.20B $77.64B
流动负债合计 $27.73B $26.95B $28.33B $28.33B $28.63B
应付款 $10.18B $9.95B $11.27B $11.27B $11.04B
-应付账款 $3.83B $3.86B $4.40B $4.40B $4.15B
-应付税款合计 $4.22B $3.95B $4.73B $4.73B $4.85B
-应付股利 $2.13B $2.14B $2.14B $2.14B $2.04B
一年内应计费用 $14.73B $14.55B $14.47B $14.47B $16.19B
短期债务及融资租赁负债 $2.83B $2.44B $2.59B $2.59B $1.41B
-一年内到期债务 $2.83B $2.44B $2.59B $2.59B $1.41B
非流动负债合计 $60.09B $55.81B $55.88B $55.88B $49.01B
长期债务及融资租赁负债 $51.08B $46.67B $46.75B $46.75B $39.97B
-长期债务 $51.08B $46.67B $46.75B $46.75B $39.97B
一年以上递延负债 $1.43B $1.49B $1.44B $1.44B $1.38B
其他非流动负债 $7.57B $7.64B $7.69B $7.69B $7.66B
股东权益合计 $41.98B $45.93B $52.66B $52.66B $51.91B
股东权益 $41.93B $45.88B $52.61B $52.61B $51.85B
股本 $1.79B $1.79B $1.79B $1.79B $1.79B
-普通股 $1.79B $1.79B $1.79B $1.79B $1.79B
资本公积 $44.95B $45.18B $45.03B $45.03B $44.83B
留存收益 $63.27B $66.72B $73.08B $73.08B $72.23B
减:库存股 $64.13B $63.75B $63.00B $63.00B $61.80B
不影响留存收益的损益 -$3.94B -$4.06B -$4.29B -$4.29B -$5.20B
少数股东权益 $51.00M $53.00M $56.00M $56.00M $57.00M
-可供出售证券 – – $956.00M $956.00M $1.12B

现金流量表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
经营活动现金流 $5.37B $3.92B $16.47B $2.86B $7.82B
持续经营经营活动现金流净额 $5.37B $3.92B $16.47B $2.86B $7.82B
持续经营净利润 -$1.34B -$4.24B $18.26B $2.96B $5.79B
持续经营损益 -$243.00M -$168.00M -$368.00M $195.00M -$374.00M
折旧、折耗与摊销 $1.58B $1.51B $5.84B $2.47B $1.15B
递延税款 -$544.00M -$315.00M -$1.67B -$825.00M -$212.00M
其他非现金项目 $5.19B $8.56B $511.00M $118.00M -$51.00M
营运资金变动 $423.00M -$1.61B -$6.98B -$2.32B $1.31B
投资活动现金流净额 -$5.60B -$10.21B -$13.74B -$11.20B -$283.00M
持续经营投资活动现金流净额 -$5.60B -$10.21B -$13.74B -$11.20B -$283.00M
资本支出 -$893.00M -$991.00M -$4.11B -$1.03B -$987.00M
业务购买及出售净额 -$5.84B -$8.78B -$10.04B -$10.04B $0.00
投资购置及出售净额 $1.16B -$374.00M $471.00M $46.00M $575.00M
其他投资变动净额 -$22.00M -$66.00M -$58.00M -$172.00M $129.00M
筹资活动现金流 $1.76B -$2.98B -$1.92B $4.75B $2.64B
持续经营筹资活动现金流净额 $1.76B -$2.98B -$1.92B $4.75B $2.64B
债务发行及偿还净额 $4.89B -$79.00M $11.38B $7.85B $6.02B
普通股发行净额 -$757.00M -$874.00M -$5.08B -$1.25B -$1.32B
已付现金股利 -$2.14B -$2.11B -$8.18B -$2.02B -$2.03B
股票期权行使所得 $43.00M $157.00M $92.00M $47.00M $14.00M
其他筹资费用净额 -$270.00M -$80.00M -$131.00M $121.00M -$46.00M
期末现金余额 $6.89B $5.40B $14.69B $14.69B $18.26B
现金净变动 $1.53B -$9.27B $809.00M -$3.59B $10.18B
期初现金余额 $5.40B $14.69B $13.32B $18.26B $8.07B
汇率变动影响 -$37.00M -$19.00M $563.00M $23.00M $10.00M
自由现金流 $4.48B $2.93B $12.36B $1.82B $6.84B
-应收款变动 – – -$1.09B – –
-存货变动 – – -$1.18B – –
-应付账款及应计费用变动 – – -$1.59B – –
-其他流动负债变动 – – $195.00M – –
-其他营运资金变动 – – -$3.31B – –

讨论区

暂无评论——快来第一个聊聊 MRK。

发表评论

Scroll to Top